APA (7th ed.) Citation

Lariosa-Willingham, K., Leonoudakis, D., Bragge, T., Tolppanen, L., Nurmi, A., Flanagan, M., . . . Miszczuk, D. (2022). An in vivo accelerated developmental myelination model for testing promyelinating therapeutics. BMC Neuroscience, 23(1), 1. https://doi.org/10.1186/s12868-022-00714-y

Chicago Style (17th ed.) Citation

Lariosa-Willingham, Karen, et al. "An in Vivo Accelerated Developmental Myelination Model for Testing Promyelinating Therapeutics." BMC Neuroscience 23, no. 1 (2022): 1. https://doi.org/10.1186/s12868-022-00714-y.

MLA (9th ed.) Citation

Lariosa-Willingham, Karen, et al. "An in Vivo Accelerated Developmental Myelination Model for Testing Promyelinating Therapeutics." BMC Neuroscience, vol. 23, no. 1, 2022, p. 1, https://doi.org/10.1186/s12868-022-00714-y.